Clinical classification of benzodiazepines from a kinetico-pharmacological viewpoint
Ochs, H.R.; Verburg-Ochs, B.
Die Medizinische Welt 34(7): 207-211
1983
ISSN/ISBN: 0025-8512 PMID: 6835087 Document Number: 218123
Document emailed within 1 workday
Related Documents
Thunus, L. 1977: Synthesis of various isopropylpiperazinylpyridines from the viewpoint of their pharmacological study (substitution 2,3 and 3,4) Annales Pharmaceutiques Francaises 35(3-4): 113-117Jakubowicz, K.; Kik, A. 1982: Current classification of malignant lymphoproliferative disorders (lymphoma) from the dermatological viewpoint Przeglad Dermatologiczny 69(1-2): 1-7
Salzman, C. 1991: Benzodiazepines in medical practice. Report of the Study Group of the American Psychiatric Society (APA Task Force) on dependence, toxicity and abuse of benzodiazepines Der Nervenarzt 62(1): 61-63
Douki, S. 1991: Plea for benzodiazepines or is there a future for benzodiazepines in psychiatry? L'Encephale 17(2): 57-59
Kalayanarooj, S. 2011: Dengue classification: current WHO vs. the newly suggested classification for better clinical application? Journal of the Medical Association of Thailand 94(Suppl 3): S74-S84
García-Pedrajas, F.; Monedero, P. 1992: Benzodiazepines in anesthesiology. Clinical applications (II) Revista Espanola de Anestesiologia y Reanimacion 39(2): 126-131
Morjen, M.; Abdelkafi-Koubaa, Z.; Luis, J.; Othman, H.; Srairi-Abid, N.; El Ayeb, M.; Marrakchi, N. 2014: Snake venom Kunitz/BPTi family: Structure, classification and pharmacological potential Archives de l'Institut Pasteur de Tunis 91(1-4): 3-13
Gwee, M.C. 1985: Benzodiazepines: pharmacokinetic profile and clinical implications Annals of the Academy of Medicine Singapore 14(1): 95-103
Lee, C.Y. 1972: Classification of polypeptide toxins from elapid and sea snake venoms according to their pharmacological properties and chemical structures Journal of the Formosan Medical Association 71(6): 311-317
Luderer, H.J.; Schulz, M.; Mayer, M. 1995: Long-term administration of benzodiazepines--disease follow-up, sequelae, treatment. A retrospective clinical record evaluation of 194 patients Psychiatrische Praxis 22(6): 231-234
May, B.; Helmstaedt, D. 1975: Liver disease in drug addicts: clinical course-toxicological and clinical pharmacological aspects International Journal of Clinical Pharmacology and Biopharmacy 12(1-2): 50-56
Shilling, R.A.; Subramanian, N.; Dowlati, A.; Gordon, S.; Ramnes, C.; Sedransk, N.; Lederman, M.; Remick, S.C. 1999: A composite clinical stage for AIDS-related Kaposis sarcoma A refinement of the AIDS clinical trials group clinical staging classification JAIDS Journal of Acquired Immune Deficiency Syndromes 21(1): A23
Solomon, K.; Hart, R. 1978: Pitfalls and prospects in clinical research on antianxiety drugs: benzodiazepines and placebo--a research review Journal of Clinical Psychiatry 39(11): 823-831
Blaha, L. 1978: Clobazam from the clinical viewpoint Die Medizinische Welt 29(37): 1460-1462
Yamamoto, Y. 2006: Clinical classification of lacunar infarction--clinical pattern and lesion site Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 8): 139-143
Rabe, E. 1999: Artificial lymphedema from the clinical viewpoint WienerMedizinischeWochenschrift 149(2-4): 95
Precht, K.; Buder, H.W.; Briedigkeit, H.; Schimmelpfennig, R. 1980: Chronic pyelonephritis from a clinical viewpoint Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 35(14): 27-30
McKinley, R.E. 1972: Clinical trials from the industry viewpoint Journal of the American Veterinary Medical Association 161(11): 1391-1394
Hitzenberger, G. 1996: ACE inhibitors from the viewpoint of the clinical pharmacologist Wiener Medizinische Wochenschrift 146(11): 225-227
Raab, W.; Kleinsorge, H. 1970: Drug allergies from the viewpoint of the clinical pharmacologist Internationale Zeitschrift für Klinische Pharmakologie Therapie und Toxikologie. International Journal of Clinical Pharmacology Therapy and Toxicology 3(3): 245-254